Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter

Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter

US Patent 11999973 · Granted Jun 4, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitr2025
Methods and compositions utilizing RRx-001 combination therapy for radioprotecti2025
Methods and compositions utilizing RRx-001 combination therapy for radioprotecti2025
Personalized cancer vaccines2025
Personalized cancer vaccines2025
Personalized cancer vaccines2025
A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A 2025
A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A 2025
A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A 2025
Recombinant adenoviruses carrying transgenes2025
Recombinant adenoviruses carrying transgenes2025
Recombinant adenoviruses carrying transgenes2025